通过PSD-95蛋白质对NMDA受体激活与氧化神经毒性的特定合
1Toronto Western Hospital, University of Toronto, Lab 11-416, 399 Bathurst Street, Toronto, Ontario M5T 2S8, Canada.
Science (New York, N.Y.)
|June 12, 1999
概括
后突触密度-95 (PSD-95) 蛋白对于N-甲基-D-酸盐受体 (NMDAR) 兴奋毒性至关重要. 抑制PSD-95可以选择性地阻断NMDAR介导的氧化信号,防止神经元损伤.
科学领域:
- 神经科学是一个神经科学.
- 蜂信号传输是如何进行的
- 神经生物学 神经生物学 神经生物学
背景情况:
- N-甲基-D-酸盐受体 (NMDARs) 在神经元功能中发挥着关键作用,包括可塑性,发育和疾病.
- 这些过程中,NMDAR介导的细胞内信号传输的效率至关重要.
- NMDARs是由像后突触密度-95 (PSD-95) 这样的支架蛋白调节的.
研究的目的:
- 调查PSD-95在NMDAR引发的兴奋毒性中的特定作用.
- 为了确定PSD-95是否影响NMDAR功能或下游信号通路.
- 阐明PSD-95调解兴奋毒性信号的机制.
主要方法:
- 利用培养的皮质神经元.
- 使用遗传或分子技术抑制PSD-95的表达.
- 评估NMDAR和其他离子通道诱导的兴奋毒性.
- 测量了NMDAR电流,离子 (Ca2+) 负载和氧化产量.
- 评估了神经元氧化合成酶 (nNOS) 的表达和功能.
主要成果:
- 抑制PSD-95选择性减弱NMDAR介导的兴奋毒性,而不影响其他谷氨酸酸或Ca2+通道.
- 在PSD-95抑制后,NMDAR功能,包括受体表达,NMDA电流和Ca2+流入,在PSD-95抑制后保持不变.
- 抑制PSD-95特别阻断了Ca2+激活的氧化下游NMDARs的生产.
- 神经中氧化合成酶的表达和功能不受PSD-95抑制的影响.
结论:
- PSD-95对于有效地将NMDAR活性与氧化中介毒性的合至关重要.
- PSD-95赋予了NMDARs对刺激性Ca2+信号传递的特异性.
- 针对PSD-95可能提供一种选择性的方法,以减轻神经系统疾病中依赖NMDAR的兴奋毒性.
更多相关视频
04:48A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
07:11Examination of Anatomical Features of Retinal Ganglion Cells Under N-methyl-D-aspartic Acid (NMDA)-induced Excitotoxicity
Published on: September 19, 2025
相关概念视频
01:35Long-term Potentiation
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...